HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B P Morgan Selected Research

Myasthenia Gravis

11/2006Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats.
11/2006The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B P Morgan Research Topics

Disease

5Inflammation (Inflammations)
03/2010 - 01/2000
5Arthritis (Polyarthritis)
09/2004 - 02/2000
4Macular Degeneration (Age-Related Maculopathy)
01/2021 - 11/2008
4Rheumatoid Arthritis
09/2004 - 11/2000
4Hemolysis
07/2001 - 01/2000
3Multiple Sclerosis
10/2012 - 11/2001
3Demyelinating Diseases (Demyelinating Disease)
02/2010 - 08/2002
2Infections
02/2012 - 01/2000
2Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
11/2008 - 07/2001
2Myasthenia Gravis
11/2006 - 11/2006
2Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
11/2006 - 11/2006
2Neuromuscular Diseases (Neuromuscular Disease)
11/2006 - 11/2006
2Glomerulonephritis
03/2004 - 08/2002
2Synovitis
11/2000 - 02/2000
2Experimental Arthritis
11/2000 - 01/2000
1Acute Disease
06/2015
1Alzheimer Disease (Alzheimer's Disease)
01/2013
1Atypical Hemolytic Uremic Syndrome
04/2010
1Disease Progression
03/2010
1Meningococcal Meningitis
09/2009
1Meningitis
09/2009
1Immune Complex Diseases (Immune Complex Disease)
11/2008
1Reperfusion Injury
11/2008
1Acquired Immunodeficiency Syndrome (AIDS)
11/2008
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2008
1Nephritis
11/2008
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2004
1Encephalitis (Encephalitis, Rasmussen)
12/2004
1Neoplasms (Cancer)
03/2004
1Dementia (Dementias)
11/2002
1Postpartum Thyroiditis (Thyroiditis, Postpartum)
03/2002
1Chronic Progressive Multiple Sclerosis
11/2001
1Proteinuria
09/2001
1Membranous Glomerulonephritis (Membranous Nephropathy)
09/2001
1Thrombosis (Thrombus)
07/2001
1Necrosis
08/2000
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2000
1Hepatocellular Carcinoma (Hepatoma)
08/2000
1Acute-Phase Reaction
08/2000
1Joint Diseases (Joint Disease)
01/2000

Drug/Important Bio-Agent (IBA)

28Complement System Proteins (Complement)IBA
01/2021 - 01/2000
7Complement Membrane Attack Complex (Membrane Attack Complex)IBA
08/2011 - 02/2000
6Proteins (Proteins, Gene)FDA Link
06/2015 - 01/2000
3Complement Receptors (Complement Receptor)IBA
06/2015 - 01/2000
3Biomarkers (Surrogate Marker)IBA
01/2013 - 02/2009
3AntigensIBA
09/2004 - 11/2000
2Complement Factor H (Factor H)IBA
01/2013 - 04/2010
2Monoclonal AntibodiesIBA
03/2010 - 09/2001
2Indicators and Reagents (Reagents)IBA
11/2008 - 08/2002
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2006 - 11/2006
2AutoantibodiesIBA
11/2006 - 11/2006
2Anaphylatoxin C5a ReceptorIBA
12/2004 - 02/2000
2A-factor (Streptomyces)IBA
11/2000 - 08/2000
1Serine (L-Serine)FDA Link
01/2013
1Retinal Pigments (Pigments, Visual)IBA
08/2011
1Retinaldehyde (Retinal)IBA
03/2010
1AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)IBA
12/2004
1Peptides (Polypeptides)IBA
12/2004
1Immunoglobulins (Immunoglobulin)IBA
11/2001
1Collagen Type II (Type II Collagen)IBA
10/2001
1Low Density Lipoprotein Receptor-Related Protein-2IBA
09/2001
1AntibodiesIBA
09/2001
1cobra venom factorIBA
07/2001
1Hemoglobins (Hemoglobin)IBA
07/2001
1GlycolipidsIBA
07/2001
1CytokinesIBA
08/2000
1Interleukin-6 (Interleukin 6)IBA
08/2000
1Glycophorins (Glycophorin C)IBA
01/2000
1VenomsIBA
01/2000
1Complement Inactivating AgentsIBA
01/2000
1CD55 Antigens (Decay Accelerating Factor)IBA
01/2000

Therapy/Procedure

2Therapeutics
08/2002 - 11/2000
1Intravenous Administration
02/2000